Researcher.Life Logo

Nanomedicine: Nanotechnology, Biology, and Medicine : Impact Factor & More

eISSN: 1549-9642pISSN: 1549-9634

Key Metrics

CiteScore
12
Eigenfactor
0.01 - 0.05
H-Index
143
Impact Factor
5 - 10
SJR
Q1Bioengineering
SNIP
1.05
Recommended pre-submission checks
Powered by Paperpal by Editage

Topics Covered on Nanomedicine: Nanotechnology, Biology, and Medicine

Nanomedicine: Nanotechnology, Biology, and Medicine Journal Specifications

Overview
Publisher ELSEVIER
Language English
Frequency Bi-monthly
General Details
LanguageEnglish
FrequencyBi-monthly
Publication Start Year2005
Publisher URLVisit website
Website URLVisit website
View less

Planning to publish in Nanomedicine: Nanotechnology, Biology, and Medicine ?

Upload your Manuscript to get

  • Degree of match
  • Common matching concepts
  • Additional journal recommendations
Free Report

Recently Published Papers in Nanomedicine: Nanotechnology, Biology, and Medicine

Biomimetic lipid nanoparticles mediated metabolic regulation and sonodynamic therapy for glioblastoma immunotherapy.
  • 1 Jul 2026
  • Nanomedicine : nanotechnology, biology, and medicine
PEGylation-associated hemodynamic effects in a rodent model of acute hypersensitivity reaction: Complement activation-mediated mechanisms.
  • 23 Jun 2026
  • Nanomedicine : nanotechnology, biology, and medicine
The evolving landscape of osteoarthritis management: From conventional pharmacotherapy to gene therapy, stem cell therapy and nanotechnology-based therapeutics.
  • 23 Jun 2026
  • Nanomedicine : nanotechnology, biology, and medicine
Dihydroartemisinin-stachyose conjugate (sDHA) improves the oral bioavailability of dihydroartemisinin and antiemphalitic malaria effects.
  • 22 Jun 2026
  • Nanomedicine : nanotechnology, biology, and medicine
L220-derived peptide-bioconjugated carbon nanotubes protect hamsters against amoebic liver abscess through IL-17A-associated immune response.
  • 18 Jun 2026
  • Nanomedicine : nanotechnology, biology, and medicine
CRISPR/Cas12a and nanocomposite-based electrochemical/ colorimetric parallel dual-channel aptasensor for highly sensitive LDL detection.
  • 17 Jun 2026
  • Nanomedicine : nanotechnology, biology, and medicine
Biomimetic lipid nanoparticles mediated metabolic regulation and sonodynamic therapy for glioblastoma immunotherapy.
  • 1 Jul 2026
  • Nanomedicine : nanotechnology, biology, and medicine
PEGylation-associated hemodynamic effects in a rodent model of acute hypersensitivity reaction: Complement activation-mediated mechanisms.
  • 23 Jun 2026
  • Nanomedicine : nanotechnology, biology, and medicine
The evolving landscape of osteoarthritis management: From conventional pharmacotherapy to gene therapy, stem cell therapy and nanotechnology-based therapeutics.
  • 23 Jun 2026
  • Nanomedicine : nanotechnology, biology, and medicine
Dihydroartemisinin-stachyose conjugate (sDHA) improves the oral bioavailability of dihydroartemisinin and antiemphalitic malaria effects.
  • 22 Jun 2026
  • Nanomedicine : nanotechnology, biology, and medicine
L220-derived peptide-bioconjugated carbon nanotubes protect hamsters against amoebic liver abscess through IL-17A-associated immune response.
  • 18 Jun 2026
  • Nanomedicine : nanotechnology, biology, and medicine
CRISPR/Cas12a and nanocomposite-based electrochemical/ colorimetric parallel dual-channel aptasensor for highly sensitive LDL detection.
  • 17 Jun 2026
  • Nanomedicine : nanotechnology, biology, and medicine

FAQs on Nanomedicine: Nanotechnology, Biology, and Medicine